Dr. Venstrom is the Krishnamurthi Endowed Chair in Hematologic Malignancies in the Department of Medicine, Division of Hematology/Oncology at the University of California, San Francisco. Dr. Venstrom is a physician-scientist trained in oncology and human immunology. His laboratory focuses on translating our basic knowledge of innate immunity to develop novel therapeutics for patients with cancer. Current projects in the Venstrom laboratory aim to determine the influence of natural killer (NK) immune cells in anti-tumor immunity. Dr. Venstrom completed clinical and post-graduate research training at Memorial Sloan-Kettering Cancer Center. He received his graduate medical training at Johns Hopkins Hospital, his medical degree from Vanderbilt University School of Medicine, and additional research training at the National Institutes of Health. He has published articles in the New England Journal of Medicine, Clinical Cancer Research, the Journal of Clinical Investigation, and others. He is a recipient of numerous awards and honors, including Phi Beta Kappa, Alpha Omega Alpha, a Research Scholar Award from the American Cancer Society, a Young Investigator Award from the Cancer and Leukemia Group B Foundation and a Merit Award from the American Society of Clinical Oncology.
